SPX -0.62% VIX 6.80%
FED'S ROSENGREN SAYS ECONOMY DOESN'T LOOK LIKE IT NEEDS INTEREST-RATE CUT 
U.S. STOCKS END LOWER AS EXPECTATIONS FOR HALF-POINT RATE CUT WANE 
STOCKS HAVE TURNED NEGATIVE IN THE FINAL HOUR OF TRADING FRIDAY 
DISNEY'S LIVE-ACTION 'LION KING' SHOULD RULE THE MOVIE WORLD ON THIS HOT WEEKEND 
YOU CAN NOW BUY TRUMP-BRANDED STRAWS TO COUNTER THE 'LIBERAL' PAPER VERSIONS 
DEEP DIVE: BIG-BANK EARNINGS POINT TO NEAR-TERM PAIN AND LONG-TERM OPPORTUNITY 
CONSUMERS REMAIN UPBEAT ABOUT U.S. ECONOMY, UNIV. OF MICH. DATA SHOW 
'RELIEF' RALLY IN BOEING A KEY FACTOR IN KEEPING DOW IN POSITIVE TERRITORY 
RED ROBIN SHARES SOAR AFTER ACTIVIST-INVESTOR OFFER 
MICROSOFT HITS ALL-TIME INTRADAY HIGH AS IT JOINS BOEING IN PACING DOW ADVANCE 
Fri, Jul 19 7:52pm


AbbVie Inc [ABBV]
$68.54 0.29 (0.42%)

ABBV Profile

Sector Health Care
Industry Biotech & Pharma
Market Cap 100.90 Billion
ABBV Description

AbbVie is a drug company with a strong exposure to immunology and oncology. The company's top drug, Humira, represents over half of the company's current profits. The company was spun off from Abbott in early 2013.


Visit Website

ABBV Earnings

EPS 1.65 P/E Ratio 22.14
Previous Earnings Thu, Apr 25, 2019
Latest Earnings Fri, Jul 26, 2019 (In 7 days)

ABBV Dividend

Yield 6.24% / $4.28
Ex-Date Fri, Jul 12, 2019 (7 days ago)
Pay Date Thu, Aug 15, 2019
History 27 Payments (Quarterly)

ABBV Charts

$65.06
52 Week Range
$99.15
Jun 25, 2019
Aug 17, 2018



Symbol Price Day % YTD %
ABBV $68.54 0.42% -23.19%

Symbol Surfing

How can we make Symbol Surfing better?

info@symbolsurfing.com

Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.



©2019 Symbol Surfing All Rights Reserved.

Cookies Policy | Terms Of Service | Privacy Policy